According to recent survey results published in the October issue of The American Journal of Tropical Medicine and Hygiene, obstetricians and gynecologists in the United States are unfamiliar with Chagas' disease, a condition that affects an estimated 300,000 people in the United States and can...
Merck announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects...
The U.S. Food and Drug Administration approved a second test to screen blood, tissue and organ donors for a blood-borne parasite, Trypanosoma cruzi (T. cruzi), that causes Chagas disease, a serious and potentially fatal parasitic infection. The test, called Abbott Prism Chagas [Trypanosoma...
New research shows how the migration and settlement patterns associated with the rapid urbanization of Peru may link to Chagas disease transmission. The study, published December 15 in the open-access journal PLoS Neglected Tropical Diseases, suggests that the practice of...
New research shows how the migration and settlement patterns associated with the rapid urbanization of Peru may link to Chagas disease transmission. The study, published December 15 in the open-access journal PLoS Neglected Tropical Diseases, suggests that the practice of...